27252817|t|An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease
27252817|a|BACKGROUND There is no convenient cheap pragmatic experimental model for Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH). Our objective was to create a pragmatic model of NAFLD / NASH. METHODS Sprague-Dawley rats were fed a high-fat, high sugar homemade diet ad libitum for seven weeks. The high-fat, high sugar diet included 59% of energy derived from fat, 30% from carbohydrates, and 11% from protein. Serum levels of fasting glucose, triglyceride, cholesterol, liver enzymes, insulin, and hepatic tumor necrosis factor-alpha (TNF-α) gene expression were determined. Hepatic histology was examined by H&E stain. RESULTS Rats fed the high-fat, high sugar diet developed hepatic steatosis, and a moderate inflammation, which was associated with increased serum levels of liver enzymes, glucose, insulin, triglyceride, cholesterol, and hepatic TNF-α gene expression. CONCLUSION This rat model resembles the key features of human NAFLD / NASH and provides a simple pragmatic experimental model for elucidating the disease prevention and treatment.
27252817	18	46	Pragmatic Experimental Model	T204	UMLS:C0887965
27252817	50	82	Nonalcoholic Fatty Liver Disease	T038	UMLS:C0400966
27252817	123	151	pragmatic experimental model	T204	UMLS:C0887965
27252817	156	188	Nonalcoholic Fatty Liver Disease	T038	UMLS:C0400966
27252817	190	195	NAFLD	T038	UMLS:C0400966
27252817	198	226	Nonalcoholic Steatohepatitis	T038	UMLS:C3241937
27252817	228	232	NASH	T038	UMLS:C3241937
27252817	265	280	pragmatic model	T204	UMLS:C0887965
27252817	284	289	NAFLD	T038	UMLS:C0400966
27252817	292	296	NASH	T038	UMLS:C3241937
27252817	306	325	Sprague-Dawley rats	T204	UMLS:C0034715
27252817	337	345	high-fat	T058	UMLS:C0521974
27252817	347	371	high sugar homemade diet	T058	UMLS:C1445913
27252817	404	412	high-fat	T058	UMLS:C0521974
27252817	414	429	high sugar diet	T058	UMLS:C1445913
27252817	466	469	fat	T103	UMLS:C0012171
27252817	480	493	carbohydrates	T168	UMLS:C0453802
27252817	508	515	protein	T168	UMLS:C0453858
27252817	517	548	Serum levels of fasting glucose	T058	UMLS:C0583334
27252817	550	562	triglyceride	T058	UMLS:C0542495
27252817	564	575	cholesterol	T058	UMLS:C1445957
27252817	577	590	liver enzymes	T058	UMLS:C0428321
27252817	592	599	insulin	T058	UMLS:C0428357
27252817	605	612	hepatic	T082	UMLS:C0205054
27252817	613	640	tumor necrosis factor-alpha	T103	UMLS:C1456820
27252817	642	647	TNF-α	T103	UMLS:C1456820
27252817	649	664	gene expression	T038	UMLS:C0017262
27252817	682	689	Hepatic	T082	UMLS:C0205054
27252817	690	699	histology	T058	UMLS:C0344441
27252817	716	725	H&E stain	T058	UMLS:C0523207
27252817	735	739	Rats	T204	UMLS:C0034721
27252817	748	756	high-fat	T058	UMLS:C0521974
27252817	758	773	high sugar diet	T058	UMLS:C1445913
27252817	784	801	hepatic steatosis	T038	UMLS:C0015695
27252817	809	830	moderate inflammation	T033	UMLS:C0522568
27252817	858	897	increased serum levels of liver enzymes	T033	UMLS:C0857093
27252817	899	906	glucose	T033	UMLS:C0583332
27252817	908	915	insulin	T033	UMLS:C1261415
27252817	917	929	triglyceride	T033	UMLS:C1287372
27252817	931	942	cholesterol	T033	UMLS:C1287371
27252817	948	955	hepatic	T082	UMLS:C0205054
27252817	956	961	TNF-α	T103	UMLS:C1456820
27252817	962	977	gene expression	T038	UMLS:C0017262
27252817	995	998	rat	T204	UMLS:C0034721
27252817	999	1004	model	T204	UMLS:C0887965
27252817	1035	1040	human	T204	UMLS:C0086418
27252817	1041	1046	NAFLD	T038	UMLS:C0400966
27252817	1049	1053	NASH	T038	UMLS:C3241937
27252817	1076	1104	pragmatic experimental model	T204	UMLS:C0887965
27252817	1148	1157	treatment	T058	UMLS:C0087111